a. Select the most promising compounds for in vivo testing in animal models (e.g., rodents, dogs, or non-human primates). b. Assess the compounds' ability to block AVP-induced vasoconstriction, while also evaluating their pharmacokinetics and toxicity.
If you need to purchase chemical raw materials, submit your demand information to get the latest quotations.